Abstract
| - Cardiovascular disease accounts for around 60% of deaths in people with type 2 diabetes mellitus, and diabetes is the leading cause of renal dysfunction and premature death in the UK.1,2 A key factor in these outcomes is that many people with type 2 diabetes also have raised blood pressure, which increases the likelihood of vascular complications.3-5 Lowering elevated blood pressure, using one or more antihypertensive drugs, reduces illness and mortality rates in such people.6,7 National guidelines advocate the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin-II receptor antagonists in selected patients with type 2 diabetes.3,8,9 Here we review whether such treatment offers advantages over other antihypertensive drugs.
|